Here, we found that the 4-gene ISR signature (DDIT3, GADD45B, CRYBA4, and HSPA1L) is strongly associated with poor prognosis in CRC patients, but also with sensitivity to BR in vitro and in vivo. Our model (Fig. 6j) helps explain this paradox. This evidence concerns the gene DDIT3 and colorectal carcinoma.